Skip to content

Temporal Interference for Essential Tremor

Efficacy and Safety of Non-invasive Temporal Interference Stimulation in the Treatment of Essential Tremor: A Pilot Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07016425
Enrollment
10
Registered
2025-06-11
Start date
2025-06-09
Completion date
2026-09-30
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Tremor

Keywords

Temporal Interference, Essential Tremor

Brief summary

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.

Detailed description

Temporal Interference (TI) technology is a novel non-invasive method for deep brain stimulation (DBS). By generating an overlapping electric field from safe currents, TI creates focused stimulation in targeted deep brain areas. This approach allows for the exploration of deep brain nuclei functions and has the potential to serve as a non-invasive alternative to traditional invasive DBS for clinical treatments. This study aims to investigate the treatment efficacy of TI deep brain stimulation by including essential tremor patients aged 30-70. Before and after TI stimulation, clinical data will be recorded. Clinical and imaging data will be analyzed and processed to advance the treatment of essential tremor.

Interventions

Researchers apply temporal interference (TI) stimulation to the deep brain nuclei of essential tremor patients.

Sponsors

Liankun_Ren
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb; * No history of mental diseases; * Informed consent signed.

Exclusion criteria

* Presence of other neurological diseases affecting the study (such as epilepsy); * Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points); * Orthopedic diseases that may affect motor symptoms; * Patients taking antipsychotic or antidepressant medications; * Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers); * History of electroconvulsive therapy; * Presence of cardiovascular risk factors, etc.

Design outcomes

Primary

MeasureTime frameDescription
Tremor Level EvaluationUp to 3 months after TI stimulationPercentage change in per month after stimulation from baseline in The Essential Tremor Rating Assessment Scale(TETRAS) score. The TETRAS score ranges from 0 to 112, including an activities of daily living (ADL) section(0-48 scores) and a performance section(0-64 scores), with higher scores representing more severe tremor and lower scores indicating lower tremor level

Countries

China

Contacts

Primary ContactLiankun Ren, MD
renlk2022@outlook.com+86 13681576621

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026